NEWSMAX @NEWSMAX
Pfizer and its partner BioNTech said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years. https://t.co/xPIXrEDEFm — PolitiTweet.org